Rain intends to build a targeted oncology platform, with the first program, tarloxotinib (Tarlox), holding promise across various indications
Tarlox Development Overview
| Indication | Discovery | Preclinical | Phase 1 | Phase 2 |
|---|---|---|---|---|
Tarloxotinib |
||||
Undisclosed Indication |
||||